Logo image of LHDX

LUCIRA HEALTH INC (LHDX) Stock Fundamental Analysis

NASDAQ:LHDX - Nasdaq - US54948U1051 - Common Stock - Currency: USD

0.4523  -0.11 (-19.23%)

After market: 0.405 -0.05 (-10.46%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LHDX. LHDX was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of LHDX have multiple concerns. LHDX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LHDX had negative earnings in the past year.
In the past year LHDX has reported a negative cash flow from operations.
LHDX Yearly Net Income VS EBIT VS OCF VS FCFLHDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 -20M -40M -60M -80M -100M

1.2 Ratios

LHDX has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LHDX Yearly ROA, ROE, ROICLHDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 200 -200

1.3 Margins

LHDX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LHDX Yearly Profit, Operating, Gross MarginsLHDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 -2K -4K -6K -8K -10K

More info and screens

1

2. Health

2.1 Basic Checks

LHDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LHDX has more shares outstanding
There is no outstanding debt for LHDX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LHDX Yearly Shares OutstandingLHDX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 10M 20M 30M
LHDX Yearly Total Debt VS Total AssetsLHDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

LHDX has an Altman-Z score of -2.89. This is a bad value and indicates that LHDX is not financially healthy and even has some risk of bankruptcy.
LHDX has a worse Altman-Z score (-2.89) than 67.76% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that LHDX is not too dependend on debt financing.
LHDX has a worse Debt to Equity ratio (0.48) than 67.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z -2.89
ROIC/WACCN/A
WACC8.96%
LHDX Yearly LT Debt VS Equity VS FCFLHDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 100M -100M

2.3 Liquidity

LHDX has a Current Ratio of 1.46. This is a normal value and indicates that LHDX is financially healthy and should not expect problems in meeting its short term obligations.
LHDX's Current ratio of 1.46 is on the low side compared to the rest of the industry. LHDX is outperformed by 84.11% of its industry peers.
LHDX has a Quick Ratio of 1.46. This is a bad value and indicates that LHDX is not financially healthy enough and could expect problems in meeting its short term obligations.
LHDX has a Quick ratio of 0.79. This is amonst the worse of the industry: LHDX underperforms 87.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 0.79
LHDX Yearly Current Assets VS Current LiabilitesLHDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

LHDX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -84.60%.
LHDX shows a strong growth in Revenue. In the last year, the Revenue has grown by 564.27%.
EPS 1Y (TTM)-84.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-570.21%
Revenue 1Y (TTM)564.27%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%129.63%

3.2 Future

LHDX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.35% yearly.
Based on estimates for the next years, LHDX will show a very strong growth in Revenue. The Revenue will grow by 30.23% on average per year.
EPS Next Y83%
EPS Next 2Y25.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year201.55%
Revenue Next 2Y30.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

LHDX Yearly Revenue VS EstimatesLHDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
LHDX Yearly EPS VS EstimatesLHDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LHDX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LHDX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LHDX Price Earnings VS Forward Price EarningsLHDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LHDX Per share dataLHDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

LHDX's earnings are expected to grow with 25.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.35%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LHDX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUCIRA HEALTH INC

NASDAQ:LHDX (3/3/2023, 8:01:46 PM)

After market: 0.405 -0.05 (-10.46%)

0.4523

-0.11 (-19.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-09 2023-03-09
Earnings (Next)05-10 2023-05-10
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.86%
Ins Owner Change0%
Market Cap18.36M
Analysts43.33
Price Target0.77 (70.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-367.7%
Min EPS beat(2)-705.63%
Max EPS beat(2)-29.76%
EPS beat(4)2
Avg EPS beat(4)-10.85%
Min EPS beat(4)-705.63%
Max EPS beat(4)590.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.94%
Min Revenue beat(2)-14.7%
Max Revenue beat(2)2.82%
Revenue beat(4)3
Avg Revenue beat(4)9.87%
Min Revenue beat(4)-14.7%
Max Revenue beat(4)47.42%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-280.95%
EPS NY rev (1m)0%
EPS NY rev (3m)43.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-52.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-3.19
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-2.67
FCFYN/A
OCF(TTM)-2.03
OCFYN/A
SpS5.23
BVpS1.5
TBVpS1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 398.51%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 0.79
Altman-Z -2.89
F-Score2
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)2388.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-570.21%
EPS Next Y83%
EPS Next 2Y25.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)564.27%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%129.63%
Revenue Next Year201.55%
Revenue Next 2Y30.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-104.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-193.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-352.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-347.8%
OCF growth 3YN/A
OCF growth 5YN/A